Meves Pharmaceuticals
New York, US · Founded 2016 · Delaware corporation
Founders & leadership
RG
Rishi GuptaNamed on SEC filing
PB
Peter BarberNamed on SEC filing
JG
Joshua GrassNamed on SEC filing
BA
Ben AuspitzNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 round · 2018
▶$10.9MraisedMar 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$10.9MraisedMar 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rishi GuptaDirector
- Peter BarberDirector
- Joshua GrassExecutive Officer, Director
- Ben AuspitzDirector
- Offering amount
- $30.9M
- Amount sold
- $10.9M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Meves Pharmaceuticals raised?
- Meves Pharmaceuticals has disclosed $10.9M raised across 1 round.
- Where is Meves Pharmaceuticals headquartered?
- Meves Pharmaceuticals is headquartered in New York, US.